List of works - Daniel Wright

'Massive' metformin overdose

scientific article published on 17 April 2018

A Bayesian dose-individualization method for warfarin

scientific article

A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins

scientific article published on 13 April 2017

A Population Pharmacokinetic Model for 51Cr EDTA to Estimate Renal Function.

scientific article published on 9 December 2016

A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID-19 (SARS-COV-2) treatments

scientific article published on 08 June 2020

A factor VII-based method for the prediction of anticoagulant response to warfarin

scientific article published in Scientific Reports

A general empirical model for renal drug handling in pharmacokinetic analyses.

scientific article

A philosophical framework for pharmacy in the 21st century guided by ethical principles

scientific article published on 28 April 2017

A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis

scientific article published on 28 September 2016

A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time

scientific article

Clinical decision-making: An essential skill for 21st century pharmacy practice

scientific article published on 07 August 2018

Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran

scientific article

Correlation between trough plasma dabigatran concentrations and estimates of glomerular filtration rate based on creatinine and cystatin C

scientific article

Dabigatran in patients with mechanical heart valves

scientific article published in January 2014

Dabigatran: rational dose individualisation and monitoring guidance is needed

scientific article published on June 29, 2012

Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models

scientific article published on 13 June 2017

Evaluation of Assumptions Underpinning Pharmacometric Models

scientific article published on 05 August 2019

Evaluation of designs for renal drug studies based on the EMA and FDA guidelines for drugs that are predominantly secreted

scientific article published on 28 August 2020

Falsely elevated vancomycin plasma concentrations sampled from central venous implantable catheters (portacaths).

scientific article published on November 2010

Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone

scientific article published on 7 August 2013

Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of gout

scientific article

Individualising the dose of allopurinol in patients with gout

scientific article published on 18 April 2017

Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool.

scientific article published on December 2016

Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint.

scientific article

Is the dose of dabigatran really more predictable than warfarin?

scientific article published on December 2013

Kinetic-pharmacodynamic model for drugs with non-linear elimination: Parameterisation matters

scientific article published on 10 January 2020

Learning more from the dabigatran concentrations in the RE-LY study

scientific article published on 26 March 2014

Letter by Chin et al regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial

scientific article published on 01 November 2014

Measuring the Development of Therapeutic-Decision-Making Skills by Practicing Pharmacists Undertaking a University-Based Postgraduate Clinical Qualification at Distance

scientific article published on 11 May 2020

Methods for Predicting Warfarin Dose Requirements.

scientific article published on August 2015

Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy

scientific article published on 09 October 2020

Model-based Drug Dosing

2013 doctoral thesis by Daniel Frank Wright at University of Otago

Predicting allopurinol response in patients with gout

scientific article published on 9 October 2015

Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration

scientific article published on 3 September 2019

Response to 'Comment on ''Massive' metformin overdose' by Chiew et al.'

scientific article published on 02 October 2018

Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!

scientific article published on 12 November 2018

Science fiction has become reality: Best practice for future viral pandemics

scientific article published on 23 July 2021

Spotlight Commentary: Model-informed precision dosing must demonstrate improved patient outcomes

scientific article published on 09 August 2019

The 'apparent clearance' of free phenytoin in elderly vs. younger adults

scientific article

The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool

scientific article published on 17 January 2018

The influence of dosing time, variable compliance and circadian low-density lipoprotein production on the effect of simvastatin: simulations from a pharmacokinetic-pharmacodynamic model.

scientific article

The intact nephron hypothesis as a model for renal drug handling

article

The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)

scientific article published on 09 December 2019

The pharmacokinetics of metformin in patients receiving intermittent haemodialysis

scientific article published on 14 February 2020

The population pharmacokinetics of allopurinol and oxypurinol in patients with gout

scientific article published on 10 March 2013

The propagation of between-subject variability from dose to response

scientific article published on 19 December 2020

Therapeutic decision-making in primary care pharmacy practice

scientific article published on 10 April 2020

The Association between Metformin Therapy and Lactic Acidosis

scientific article published on 01 December 2019

Understanding the association between metformin plasma concentrations and lactate

scientific article published on 09 June 2020

Understanding the process of clinical judgement for pharmacists when making clinical decisions

scientific article published on 10 August 2018

Understanding the time course of pharmacological effect: a PKPD approach

scientific article published on June 2011

What do we learn from repeated population analyses?

scientific article published on January 2015

List of works by Daniel Wright

'Massive' metformin overdose

A Bayesian dose-individualization method for warfarin

A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins

A Population Pharmacokinetic Model for 51Cr EDTA to Estimate Renal Function.

A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID-19 (SARS-COV-2) treatments

A factor VII-based method for the prediction of anticoagulant response to warfarin

A general empirical model for renal drug handling in pharmacokinetic analyses.

A philosophical framework for pharmacy in the 21st century guided by ethical principles

A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis

A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time

Clinical decision-making: An essential skill for 21st century pharmacy practice

Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran

Correlation between trough plasma dabigatran concentrations and estimates of glomerular filtration rate based on creatinine and cystatin C

Dabigatran in patients with mechanical heart valves

Dabigatran: rational dose individualisation and monitoring guidance is needed

Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models

Evaluation of Assumptions Underpinning Pharmacometric Models

Evaluation of designs for renal drug studies based on the EMA and FDA guidelines for drugs that are predominantly secreted

Falsely elevated vancomycin plasma concentrations sampled from central venous implantable catheters (portacaths).

Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone

Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of gout

Individualising the dose of allopurinol in patients with gout

Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool.

Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint.

Is the dose of dabigatran really more predictable than warfarin?

Kinetic-pharmacodynamic model for drugs with non-linear elimination: Parameterisation matters

Learning more from the dabigatran concentrations in the RE-LY study

Letter by Chin et al regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial

Measuring the Development of Therapeutic-Decision-Making Skills by Practicing Pharmacists Undertaking a University-Based Postgraduate Clinical Qualification at Distance

Methods for Predicting Warfarin Dose Requirements.

Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy

Model-based Drug Dosing

Predicting allopurinol response in patients with gout

Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration

Response to 'Comment on ''Massive' metformin overdose' by Chiew et al.'

Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!

Science fiction has become reality: Best practice for future viral pandemics

Spotlight Commentary: Model-informed precision dosing must demonstrate improved patient outcomes

The 'apparent clearance' of free phenytoin in elderly vs. younger adults

The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool

The influence of dosing time, variable compliance and circadian low-density lipoprotein production on the effect of simvastatin: simulations from a pharmacokinetic-pharmacodynamic model.

The intact nephron hypothesis as a model for renal drug handling

The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)

The pharmacokinetics of metformin in patients receiving intermittent haemodialysis

The population pharmacokinetics of allopurinol and oxypurinol in patients with gout

The propagation of between-subject variability from dose to response

Therapeutic decision-making in primary care pharmacy practice

The Association between Metformin Therapy and Lactic Acidosis

Understanding the association between metformin plasma concentrations and lactate

Understanding the process of clinical judgement for pharmacists when making clinical decisions

Understanding the time course of pharmacological effect: a PKPD approach

What do we learn from repeated population analyses?